share_log

Jefferies Downgrades Profound Medical to Equal-Weight, Raises Price Target to $10

Jefferies Downgrades Profound Medical to Equal-Weight, Raises Price Target to $10

富瑞將深刻醫療評級降至同等重量,將目標價格提高至 10 美元
Benzinga ·  2023/03/21 05:38

Jefferies analyst Michael Sarcone downgrades Profound Medical (NASDAQ:PROF) from Buy to Equal-Weight and raises the price target from $5.5 to $10.

傑富瑞分析師邁克爾·薩科內將深奧醫療(納斯達克:PROF)的評級從買入下調至等權重,並將目標價從5.5美元上調至10美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論